Drug class in one race
Proteasome drugs for Multiple Myeloma
4 tracked Proteasome drugs in the Multiple Myeloma race. The class explanation lives on the Proteasome page; the full indication pipeline across every mechanism is on the Multiple Myeloma page.
3 approved / phase 41 Phase 1
Head-to-head evidence: Bortezomib vs Carfilzomib · Bortezomib vs Ixazomib · Bortezomib vs TQB3602 · Carfilzomib vs Ixazomib · Carfilzomib vs TQB3602 · Ixazomib vs TQB3602